COMMUNIQUÉS West-GlobeNewswire
-
Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at Scripps’ Structural Heart Intervention and Imaging 2026 Conference
05/02/2026 -
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
05/02/2026 -
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
05/02/2026 -
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
05/02/2026 -
Basic Jane Advances Science-Led Cannabinoid Platform Focused on Senior Care and Scalable Product Formats
05/02/2026 -
Profusa Announces 1-for-75 Reverse Stock Split
05/02/2026 -
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year
05/02/2026 -
Alumis to Participate in Upcoming February Investor Conferences
05/02/2026 -
In a Defining Election Year, MAPS Releases Policy Guidebook to Shape the Future of Psychedelic Reform
05/02/2026 -
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
05/02/2026 -
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
05/02/2026 -
ADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer
05/02/2026 -
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026
05/02/2026 -
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
05/02/2026 -
Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care
05/02/2026 -
ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call
05/02/2026 -
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
05/02/2026 -
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05/02/2026 -
Proven Senior Care Model Takes Center Stage at the Capitol
05/02/2026
Pages